Recent Finacing
Recent Raise
Heartseed develops HS-001, an allogeneic iPSC-derived ventricular cardiomyocyte spheroid therapy for severe heart failure, conducting Phase 1/2 trials in Japan and advancing delivery (SEEDPLANTER, catheter), manufacturing, and logistics.
